Health insurance companies may not impose an “arbitrary limit” on coverage for naloxone, a drug used to treat narcotic overdoses, the Department of Financial Services said in a letter to insurers Sept. 28.

In the letter to insurers, the state agency said that naloxone—which blocks or reverses the effects of opioid medications such as oxycodone and fentanyl—must be covered by insurers when medically necessary.